Menu Search
Equities

Medical Properties Trust Inc

0JZZ:LSE

Medical Properties Trust Inc

Actions
  • Price (USD)4.56
  • Today's Change0.000 / 0.00%
  • Shares traded116.53k
  • 1 Year change-46.07%
  • Beta--
Data delayed at least 20 minutes, as of Apr 19 2024 19:12 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medical Properties Trust, Inc. is a self-advised real estate investment trust (REIT). The Company conducts all of its operations through its subsidiary, MPT Operating Partnership, L.P. (the Operating Partnership). It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases. It also makes mortgage loans to healthcare operators collateralized by their real estate assets. The Company selectively makes loans to certain of its operators through its taxable REIT subsidiaries (TRS). The Company has healthcare investments in the United States, Europe and South America. The Company owns hospital real estate with 434 facilities in nine countries and across three continents. The Company's financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

  • Revenue in USD (TTM)871.80m
  • Net income in USD-558.12m
  • Incorporated2003
  • Employees121.00
  • Location
    Medical Properties Trust Inc1000 Urban Center Drive, Suite 501BIRMINGHAM 35242United StatesUSA
  • Phone+1 (205) 969-3755
  • Fax+1 (205) 969-3756
  • Websitehttps://medicalpropertiestrust.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.